Weiwei Ning

494 total citations
15 papers, 369 citations indexed

About

Weiwei Ning is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Weiwei Ning has authored 15 papers receiving a total of 369 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Molecular Biology. Recurrent topics in Weiwei Ning's work include Cancer-related molecular mechanisms research (3 papers), Cancer Immunotherapy and Biomarkers (2 papers) and MicroRNA in disease regulation (2 papers). Weiwei Ning is often cited by papers focused on Cancer-related molecular mechanisms research (3 papers), Cancer Immunotherapy and Biomarkers (2 papers) and MicroRNA in disease regulation (2 papers). Weiwei Ning collaborates with scholars based in China. Weiwei Ning's co-authors include Jianjie Zhu, Zeyi Liu, Yuanyuan Zeng, Nan Zhang, Qiu‐Xia Qu, Hui Zeng, Jian-An Huang, Cheng Chen, Wenwen Du and Wenwen Du and has published in prestigious journals such as Scientific Reports, Toxicology and Applied Pharmacology and Surgical Endoscopy.

In The Last Decade

Weiwei Ning

14 papers receiving 367 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weiwei Ning China 5 228 155 117 86 66 15 369
David O. Rosenberg United States 2 230 1.0× 135 0.9× 103 0.9× 31 0.4× 51 0.8× 2 340
Stefan Stefanović Germany 9 249 1.1× 117 0.8× 89 0.8× 68 0.8× 99 1.5× 22 358
Masaru Noda Japan 8 148 0.6× 134 0.9× 157 1.3× 44 0.5× 80 1.2× 17 332
Rodrigo Perez Pereira Brazil 6 467 2.0× 155 1.0× 296 2.5× 90 1.0× 40 0.6× 11 583
Chris Hopson United States 2 296 1.3× 143 0.9× 140 1.2× 41 0.5× 28 0.4× 3 363
Colin Purcell United Kingdom 5 180 0.8× 117 0.8× 86 0.7× 54 0.6× 55 0.8× 8 297
Mohamed Abu Nada Qatar 10 281 1.2× 254 1.6× 137 1.2× 68 0.8× 66 1.0× 23 447
Tania Sarkar India 6 128 0.6× 194 1.3× 110 0.9× 32 0.4× 53 0.8× 10 331
Raquel Laza‐Briviesca Spain 9 118 0.5× 86 0.6× 206 1.8× 72 0.8× 167 2.5× 19 384
Efimia Boutsikou Greece 6 155 0.7× 54 0.3× 112 1.0× 158 1.8× 65 1.0× 12 351

Countries citing papers authored by Weiwei Ning

Since Specialization
Citations

This map shows the geographic impact of Weiwei Ning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiwei Ning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiwei Ning more than expected).

Fields of papers citing papers by Weiwei Ning

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiwei Ning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiwei Ning. The network helps show where Weiwei Ning may publish in the future.

Co-authorship network of co-authors of Weiwei Ning

This figure shows the co-authorship network connecting the top 25 collaborators of Weiwei Ning. A scholar is included among the top collaborators of Weiwei Ning based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiwei Ning. Weiwei Ning is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Ning, Weiwei, et al.. (2024). Additional EBUS-guided intralesional amphotericin B injection combined systemic intravenous therapy in pulmonary mucormycosis: a case report. Therapeutic Advances in Respiratory Disease. 18. 2693846570–2693846570. 1 indexed citations
2.
Wang, Yang, et al.. (2024). Torquetenovirus from bronchoalveolar lavage fluid as a biomarker for lung infection among immunocompromised hosts. Biomarkers in Medicine. 18(13-14). 581–591.
3.
Liu, Zhenxing, Honghong Chen, Jinlong Liang, et al.. (2024). Clinical efficacy of enhanced recovery surgery in Da Vinci robot-assisted pancreatoduodenectomy. Scientific Reports. 14(1). 21539–21539. 2 indexed citations
4.
Zhou, Danhong, Yang Wang, Weiwei Ning, & Cheng Chen. (2023). Comparison of primary and metastatic site‐related PD‐L1 expression in predicting ORR in patients with advanced NSCLC who received ICB‐based therapy. Thoracic Cancer. 15(5). 379–385. 1 indexed citations
5.
6.
Liu, Zhenxing, et al.. (2023). Top 100 cited articles in the thromboangiitis obliterans: a bibliometric analysis and visualized study. European journal of medical research. 28(1). 551–551. 4 indexed citations
7.
8.
Zhang, Beilei, et al.. (2022). A wide clinical spectrum of pulmonary affection in subjects with community-acquired Klebsiella pneumoniae liver abscess (CA-KPLA). Journal of Infection and Chemotherapy. 29(1). 48–54. 2 indexed citations
9.
Zhang, Tao, et al.. (2021). Nonylphenol regulates TL1A through the AhR/HDAC2/HNF4α pathway in endothelial cells to promote the angiogenesis of colorectal cancer. Toxicology and Applied Pharmacology. 436. 115854–115854. 4 indexed citations
10.
Wang, Xiaofei, Bo Liang, Daxiong Zeng, et al.. (2020). Long Intergenic Non-protein Coding RNA 511 in Cancers. Frontiers in Genetics. 11. 667–667. 10 indexed citations
11.
Ning, Weiwei, et al.. (2020). Treatment of a case presenting as critical adenoviral ARDS using Cidofovir with early combinatorial prone ventilation and ECMO. The Clinical Respiratory Journal. 14(8). 780–788. 1 indexed citations
12.
Liu, Ting, Jianjie Zhu, Wenwen Du, et al.. (2020). AKT2 drives cancer progression and is negatively modulated by miR-124 in human lung adenocarcinoma. Respiratory Research. 21(1). 227–227. 31 indexed citations
13.
Du, Wenwen, Jianjie Zhu, Yanbin Chen, et al.. (2017). Variant SNPs at the microRNA complementary site in the B7-H1 3′-untranslated region increase the risk of non-small cell lung cancer. Molecular Medicine Reports. 16(3). 2682–2690. 35 indexed citations
14.
Zeng, Yuanyuan, Qiu‐Xia Qu, Jianjie Zhu, et al.. (2017). PD-L1 induced by IFN-γ from tumor-associated macrophages via the JAK/STAT3 and PI3K/AKT signaling pathways promoted progression of lung cancer. International Journal of Clinical Oncology. 22(6). 1026–1033. 249 indexed citations
15.
Wang, Yuting, Weiwei Ning, Jing Li, & Jianan Huang. (2016). Exon 19 L747P mutation presented as a primary resistance to EGFR-TKI: a case report. Journal of Thoracic Disease. 8(7). E542–E546. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David O. Rosenberg Breakdown of academic impact, for papers by Stefan Stefanović Breakdown of academic impact, for papers by Masaru Noda Breakdown of academic impact, for papers by Rodrigo Perez Pereira Breakdown of academic impact, for papers by Chris Hopson Breakdown of academic impact, for papers by Colin Purcell Breakdown of academic impact, for papers by Mohamed Abu Nada Breakdown of academic impact, for papers by Tania Sarkar Breakdown of academic impact, for papers by Raquel Laza‐Briviesca Breakdown of academic impact, for papers by Efimia Boutsikou
Rankless by CCL
2026